Last reviewed · How we verify

Control continuous peripheral nerve blocks

University of California, San Diego · FDA-approved active Small molecule

A continuous peripheral nerve block system delivers local anesthetic medication directly to peripheral nerves over an extended period to provide prolonged pain relief.

A continuous peripheral nerve block system delivers local anesthetic medication directly to peripheral nerves over an extended period to provide prolonged pain relief. Used for Perioperative pain management following surgery, Chronic pain conditions amenable to peripheral nerve blockade.

At a glance

Generic nameControl continuous peripheral nerve blocks
Also known asControl perineural local anesthetic infusion
SponsorUniversity of California, San Diego
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

This is a medical device/technique rather than a traditional pharmaceutical drug. It involves placement of a catheter near a peripheral nerve with continuous or intermittent infusion of local anesthetic (typically liposomal bupivacaine or similar agents) to block nerve conduction and provide anesthesia/analgesia. The system allows for extended pain control beyond single-injection nerve blocks, typically used perioperatively or for chronic pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: